MARKET

XPH

XPH

SPDR® S&P Pharmaceuticals ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

51.00
-1.32
-2.52%
After Hours: 50.57 -0.43 -0.84% 19:24 03/04 EST
OPEN
51.90
PREV CLOSE
52.32
HIGH
52.21
LOW
50.44
VOLUME
107.41K
TURNOVER
--
52 WEEK HIGH
56.32
52 WEEK LOW
30.30
TOTAL ASSET
282.84M
YTD YIELD
-4.44%
1D
5D
1M
3M
1Y
5Y
Pharma ETFs in Focus Post Q4 Earnings
Zacks.com · 02/05 17:40
SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.0538
SPDR S&P Pharmaceuticals ETF (XPH) - $0.0538.30-Day SEC Yield of 0.44% as of Dec. 18.Payable Dec 24; for shareholders of record Dec 22; ex-div Dec 21.
Seekingalpha · 12/21/2020 20:45
Top Pharmaceutical Stocks for Q1 2021
These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q1 2021.
Investopedia · 12/07/2020 15:56
Big Pharma In Canada Offers C$1B In Last Attempt To Stop Drug Pricing Crackdown
The pharmaceutical industry has delivered a C$1 billion ($761 million) proposal to the Canadian government in an attempt to stave off an upcoming price crackdown, Reuters reported 
Benzinga · 11/15/2020 16:19
Healthcare: XLV Survey For October
A dashboard with metrics in healthcare industries.Value and quality scores, and their evolution since last month.A list of cheap stocks.
Seekingalpha · 10/18/2020 19:46
Pharma Stocks Poised to Move Higher
Nearby support on the charts suggests that the pharmaceuticals sector could be one to watch over the last few months of 2020.
Investopedia · 10/14/2020 14:01
Pharma Stocks Poised to Move Higher
Nearby support on the charts suggests that the pharmaceuticals sector could be one to watch over the last few months of 2020.
Investopedia · 10/14/2020 14:01
Pharma Stocks Poised to Move Higher
Nearby support on the charts suggests that the pharmaceuticals sector could be one to watch over the last few months of 2020.
Investopedia · 10/14/2020 13:01
More
No Data
Learn about the latest financial forecast of XPH. Analyze the recent business situations of SPDR® S&P Pharmaceuticals ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
08/31/2020
10 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-2.1617%
--
1-Week
0.0432%
--
1-Month
-0.3793%
--
3-Month
0.4992%
--
6-Month
5.0086%
--
YTD
-4.4365%
--
1-Year
25.1785%
--
3-Year
1.2186%
--
5-Year
-3.5232%
--
10-Year
9.8792%
--
Since Inception
9.4359%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
SPDR® S&P Pharmaceuticals ETF
Risk
Low risk
Inception Date
2006-06-19
Benchmark
Dow Jones US Healthcare TR
Advisor Company
State Street Global Advisors Ltd
Custodian
State Street Bank & Trust Co
Manager
Feehily/Schneider/Richardson